c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Altered glucose metabolism in cancer cells is termed the Warburg effect, which describes the propensity of most cancer cells to take up glucose avidly and convert it primarily to lactate, despite available oxygen. Notwithstanding the renewed interest in the Warburg effect, cancer cells also depend on continued mitochondrial function for metabolism, specifically glutaminolysis that catabolizes glutamine to generate ATP and lactate. Glutamine, which is highly transported into proliferating cells, is a major source of energy and nitrogen for biosynthesis, and a carbon substrate for anabolic processes in cancer cells, but the regulation of glutamine metabolism is not well understood. Here we report that the c-Myc (hereafter referred to as Myc) oncogenic transcription factor, which is known to regulate microRNAs and stimulate cell proliferation, transcriptionally represses miR-23a and miR-23b, resulting in greater expression of their target protein, mitochondrial glutaminase, in human P-493 B lymphoma cells and PC3 prostate cancer cells. This leads to upregulation of glutamine catabolism. Glutaminase converts glutamine to glutamate, which is further catabolized through the tricarboxylic acid cycle for the production of ATP or serves as substrate for glutathione synthesis. The unique means by which Myc regulates glutaminase uncovers a previously unsuspected link between Myc regulation of miRNAs, glutamine metabolism, and energy and reactive oxygen species homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [629]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MYC-driven cancer cells exhibit enhanced glutamine utilization accompanied by increased expression of key glutaminolysis enzymes, including GLS1/GLS2 and GLUD1178–180.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [178]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This was not due to increased protein levels of GLS or c-Myc, which regulates GLS expression”
From Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma (2018) · cites this paper as Gao et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“genes involved in glutamine metabolism appear to be under both the direct and indirect transcriptional control of the MYC protein (32, 33)”
From Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation (2009) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“It has long been established that Myc activation upregulates glutamine metabolism [79,80], increasing glutamine flux by upregulating the glutamine transporter (ASCT2) and glutaminase-1, thus increasing glutamine conversion to glutamate [81].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [79]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Self-citationTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337
Widespread microRNA repression by Myc contributes to tumorigenesis
Chang, T.-C., Yu, D., Lee, Y.-S., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas-Tikhonenko, A., & Mendell, J. T. (2008) · Nature Genetics · doi:10.1038/ng.2007.30 · Cited by 1,325
Self-citationYates, J. R., Eng, J. K., McCormack, A. L., & Schieltz, D. (1995) · Analytical Chemistry · doi:10.1021/ac00104a020 · Cited by 1,253
Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.
Reitzer, L. J., Wice, B. M., & Kennell, D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30124-2 · Cited by 1,240
Brick by brick: metabolism and tumor cell growth
DeBerardinis, R. J., Sayed, N., Ditsworth, D., & Thompson, C. B. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.003 · Cited by 1,018
Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927
MicroRNA Expression Profiling in Prostate Cancer
Porkka, K. P., Pfeiffer, M. J., Waltering, K. K., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0533 · Cited by 899
Cited by
Items 701–800 of 1,006
Enigmatic MYC Conducts an Unfolding Systems Biology Symphony
Dang, C. V. (2010) · Genes & Cancer · doi:10.1177/1947601910378742 · Cited by 70
Self-citationHébert-Chatelain, É., José, C., Cortés, N. G., Dupuy, J., Rocher, C., Dachary-Prigent, J., & Letellier, T. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.01.014 · Cited by 70
Ruan, W., Xu, J.-M., Li, S.-B., Yuan, L.-Q., & Dai, R.-P. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvr290 · Cited by 64
Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2
Dann, S. G., Ryskin, M., Barsotti, A. M., Golas, J., Shi, C., Miranda, M., Hosselet, C., Lemon, L., Lucas, J., Karnoub, M., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201488166 · Cited by 67
Ji, J., Qin, Y., Ren, J., Lu, C., Wang, R., Dai, X., Zhou, R., Huang, Z., Xu, M., Chen, M., et al. (2015) · Scientific Reports · doi:10.1038/srep16262 · Cited by 67
Guo, Q., Chen, Y., Guo, L., Jiang, T., & Lin, Z. (2016) · Bone Research · doi:10.1038/boneres.2016.22 · Cited by 64
Deciphering metabolic rewiring in breast cancer subtypes
Ogrodzinski, M. P., Bernard, J. J., & Lunt, S. Y. (2017) · Translational research · doi:10.1016/j.trsl.2017.07.004 · Cited by 73
Targeting MYC Proteins for Tumor Therapy
Wolf, E., & Eilers, M. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055826 · Cited by 63
Lozier, A., Rich, M. E., Grawe, A. P., Peck, A. S., Zhao, P., Chang, A., Bond, J. P., & Sholler, G. L. S. (2014) · Oncotarget · doi:10.18632/oncotarget.2768 · Cited by 64
Koufaris, C., Valbuena, G. N., Pomyen, Y., Tredwell, G. D., Nevedomskaya, E., Lau, C.-H., Yang, T.-Y., Benito, A., Ellis, J. K., & Keun, H. C. (2015) · Oncogene · doi:10.1038/onc.2015.333 · Cited by 66
EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma
Ye, Y., Zhou, Y., Zhang, L., Chen, Y., Lyu, X., Cai, L., Lu, Y., Deng, Y., Wang, J., Yao, K., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.008 · Cited by 66
Inactivation of MYC reverses tumorigenesis
Li, Y., Casey, S. C., & Felsher, D. W. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12237 · Cited by 72
MiR-27a Functions as a Tumor Suppressor in Acute Leukemia by Regulating 14-3-3θ
Scheibner, K. A., Teaboldt, B., Hauer, M. C., Chen, X., Cherukuri, S., Guo, Y., Kelley, S. M., Liu, Z., Baer, M. R., Heimfeld, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050895 · Cited by 66
Metabolic changes in cancer cells upon suppression of MYC
Anso, E., Mullen, A. R., Felsher, D. W., Matés, J. M., DeBerardinis, R. J., & Chandel, N. S. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-7 · Cited by 63
Targeting metabolism in breast cancer: How far we can go?
Long, J., Li, X.-N., & Zhang, F. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i1.122 · Cited by 75
Chen, P. R., Redel, B. K., Spate, L. D., Ji, T., Salazar, S. R., & Prather, R. S. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy129 · Cited by 69
Tenora, L., Alt, J., Dash, R. P., Gadiano, A. J., Novotná, K., Veeravalli, V., Lam, J., Kirkpatrick, Q. R., Lemberg, K. M., Majer, P., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b02009 · Cited by 64
Chen, L., Zhang, W., Chen, D., Yang, Q., Sun, S., Dai, Z., Li, Z., Liang, X., Chen, C., Jiao, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01367-x · Cited by 71
mi RNA s, polyphenols, and chronic disease
Bladé, C., Baselga‐Escudero, L., Salvadó, M. J., & Arola‐Arnal, A. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200454 · Cited by 73
MicroRNA profiling in early hypertrophic growth of the left ventricle in rats
Busk, P. K., & Cirera, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.039 · Cited by 68
Willers, I. M., & Cuezva, J. M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.016 · Cited by 73
MicroRNAs in hematological malignancies
Lawrie, C. H. (2013) · Blood Reviews · doi:10.1016/j.blre.2013.04.002 · Cited by 66
Normal and cancer cell metabolism: lymphocytes and lymphoma
Altman, B. J., & Dang, C. V. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08651.x · Cited by 62
Self-citationmiR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth
Fulciniti, M., Amodio, N., Bandi, R. L., Cagnetta, A., Samur, M., Acharya, C., PRABHALA, R. H., D’Aquila, P., Bellizzi, D., Passarino, G., et al. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2015.106 · Cited by 64
Regulation of Stem Cell Fate by ROS-mediated Alteration of Metabolism
Ryu, J. M., Lee, H. J., Jung, Y. H., Lee, K. H., Kim, D. I., Kim, J. Y., Ko, S. H., Choi, G. E., Chai, I. I., Song, E. J., et al. (2015) · International Journal of Stem Cells · doi:10.15283/ijsc.2015.8.1.24 · Cited by 65
On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer
Penkert, J., Ripperger, T., Schieck, M., Schlegelberger, B., Steinemann, D., & Illig, T. (2016) · Oncotarget · doi:10.18632/oncotarget.11759 · Cited by 67
MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis
Barros‐Silva, D., Costa‐Pinheiro, P., Duarte, H. O., Sousa, E., Evangelista, A. F., Graça, I. C. R., Carneiro, I. C., Martins, A. T., Oliveira, J., Carvalho, A. L., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0241-y · Cited by 64
Cossa, G., Roeschert, I., Prinz, F., Baluapuri, A., Silveira Vidal, R., Schülein-Völk, C., Chang, Y.-C., Ade, C. P., Mastrobuoni, G., Girard, C., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.01.008 · Cited by 61
Reid, M. A., Lowman, X. H., Pan, M., Tran, T. Q., Warmoes, M. O., Ishak Gabra, M. B., Yang, Y., Locasale, J. W., & Kong, M. (2016) · Genes & Development · doi:10.1101/gad.287235.116 · Cited by 62
Song, Z., Wei, B., Lu, C., Li, P., & Chen, L. (2017) · Oncology Letters · doi:10.3892/ol.2017.6538 · Cited by 61
Liu, L., Zhang, X., Ding, H., Liu, X., Cao, D., Liu, Y., Liu, J., Lin, C., Zhang, N., Wang, G., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01785-7 · Cited by 64
Martín‐Rufián, M., Tosina, M., Campos-Sandoval, J. A., Manzanares, E., Lobo, C., Segura, J. A., Alonso, F. J., Matés, J. M., & Márquez, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038380 · Cited by 70
Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway
Bueno, M. J., de Cedrón, M. G., Goméz-López, G., de Castro, I. P., Lisio, L. D., Montes‐Moreno, S., Martínez, N., Guerrero, M., Sánchez‐Martínez, R., Santos, J., et al. (2011) · Blood · doi:10.1182/blood-2010-10-315432 · Cited by 69
The TCA cycle transferase DLST is important for MYC-mediated leukemogenesis
Anderson, N. M., Li, D., Peng, H., Laroche, F., Mansour, M. R., Gjini, E., Aioub, M., Helman, D., Roderick, J. E., Cheng, T., et al. (2016) · Leukemia · doi:10.1038/leu.2016.26 · Cited by 66
Nitric oxide and tumor metabolic reprogramming
Lopez-Sanchez, L. M., Aranda, E., & Rodríguez‐Ariza, A. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113769 · Cited by 68
Glutathione Synthesis in Cancer Cells
Kalinina, E. V., & Гаврилюк, Л. А. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920080052 · Cited by 73
Overview of Cancer Metabolism and Signaling Transduction
Chae, H., & Hong, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010012 · Cited by 71
Liu, L., Yan, L., Chen, Y., Zeng, G.-H., Zhou, Y., Chen, H., Peng, W., He, M., & Huang, Q. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.010 · Cited by 63
MicroRNAs: tiny targets for engineering CHO cell phenotypes?
Barron, N., Sanchez, N., Kelly, P. S., & CLYNES, M. M. (2010) · Biotechnology Letters · doi:10.1007/s10529-010-0415-5 · Cited by 72
Yeung, C. L. A., Tsang, T. Y., Yau, P. L., & Kwok, T. T. (2017) · Oncotarget · doi:10.18632/oncotarget.14555 · Cited by 64
In vivo Reprogramming of Cancer Metabolism by MYC
Camarda, R., Williams, J. R., & Goga, A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00035 · Cited by 59
De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition
Tarrado‐Castellarnau, M., de Atauri, P., Tarragó‐Celada, J., Perarnau, J., Yuneva, M. O., Thomson, T. M., & Cascante, M. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167321 · Cited by 65
Sikder, M. O. F., Yang, S., Ganapathy, V., & Bhutia, Y. D. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0164-7 · Cited by 64
Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase
Zimmermann, S. C., Duvall, B. R., & Tsukamoto, T. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00327 · Cited by 61
Immunometabolism: new insights and lessons from antigen-directed cellular immune responses
Ramalho, R., Rao, M., Zhang, C., Agrati, C., Ippolito, G., Wang, F., Zumla, A. I., & Maeurer, M. J. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00798-w · Cited by 70
Advances in improving mammalian cells metabolism for recombinant protein production
Altamirano, C., Berrios, J., Vergara, M., & Becerra, S. (2013) · Electronic Journal of Biotechnology · doi:10.2225/vol16-issue3-fulltext-2 · Cited by 60
The Metabolic Heterogeneity and Flexibility of Cancer Stem Cells
Tanabe, A., & Sahara, H. (2020) · Cancers · doi:10.3390/cancers12102780 · Cited by 65
Metabolism and immunity in breast cancer
Zhang, D., Xu, X., & Ye, Q. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0793-6 · Cited by 63
MitomiRs: their roles in mitochondria and importance in cancer cell metabolism
Renčelj, A., Gvozdenovic, N., & Čemažar, M. (2021) · Radiology and Oncology · doi:10.2478/raon-2021-0042 · Cited by 76
Grabacka, M., Pierzchalska, M., & Reiss, K. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314030009 · Cited by 58
From cancer metabolism to new biomarkers and drug targets
Chiaradonna, F., Moresco, R. M., Airoldi, C., Gaglio, D., Palorini, R., Nicotra, F., Messa, C., & Alberghina, L. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.07.006 · Cited by 69
In vivo and in vitro liver cancer metabolism observed with hyperpolarized [5-13C]glutamine
Cabella, C., Karlsson, M. G., Canapè, C., Catanzaro, G., Serra, S. C., Miragoli, L., Poggi, L., Uggeri, F., Venturi, L., Jensen, P. R., et al. (2013) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2013.04.010 · Cited by 65
Khan, A. U. H., Rathore, M. G., Allende-Vega, N., Vo, D.-N., Belkhala, S., Orecchioni, S., Talarico, G., Bertolini, F., Cartron, G., Lecellier, C.-H., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.045 · Cited by 59
Mitochondrial pyruvate carrier function and cancer metabolism
Rauckhorst, A. J., & Taylor, E. B. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.05.003 · Cited by 61
Resetting cancer stem cell regulatory nodes upon MYC inhibition
Galardi, S., Savino, M., Scagnoli, F., Pellegatta, S., Pisati, F., Zambelli, F., Illi, B., Annibali, D., Beji, S., Orecchini, E., et al. (2016) · EMBO Reports · doi:10.15252/embr.201541489 · Cited by 67
Haploinsufficiency of SIRT1 Enhances Glutamine Metabolism and Promotes Cancer Development
Ren, N. S. X., Ji, M. H., Tokar, E. J., Busch, E. L., Xu, X., Lewis, D., Li, X., Jin, A., Zhang, Y., Wu, W. K. K., et al. (2017) · Current Biology · doi:10.1016/j.cub.2016.12.047 · Cited by 60
Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism
Dong, J., Xiao, D., Zhao, Z., Ren, P., Li, C., Hu, Y., Shi, J., Su, H., Wang, L., Liu, H., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.59 · Cited by 64
Self-citationTargeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective
Missiaen, R., Morales-Rodriguez, F., Eelen, G., & Carmeliet, P. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.01.001 · Cited by 58
Metabolic dependencies and targets in ovarian cancer
Zhang, Y., Wang, Y., Zhao, G., Oršulić, S., & Matei, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108413 · Cited by 75
Lucarelli, G. T., Loizzo, D., Ferro, M., Rutigliano, M., Vartolomei, M. D., Cantiello, F., Buonerba, C., Lorenzo, G. D., Terracciano, D., COBELLI, O. D., et al. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1604223 · Cited by 62
Gonsalves, W. I., Ramakrishnan, V., Hitosugi, T., Ghosh, T., Jevremovic, D., Dutta, T., Sakrikar, D., Petterson, X.-M., Wellik, L., Kumar, S. K., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.94543 · Cited by 57
Tong, Y., Li, F. Y., Lu, Y., Cao, Y., Gao, J., & Liu, J. (2013) · Molecular Reproduction and Development · doi:10.1002/mrd.22267 · Cited by 58
Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth
Zhao, J., Shi, S., Qu, H.-Y., Keckesova, Z., Cao, Z.-J., Yang, L., Yu, X., Feng, L., Shi, Z., Krakowiak, J., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-021-00524-2 · Cited by 62
Role of stress granules in tumorigenesis and cancer therapy
Li, T., Zeng, Z., Fan, C., & Xiong, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189006 · Cited by 64
Aurora kinase A mediates c‐Myc's oncogenic effects in hepatocellular carcinoma
Lu, L.-F., Han, H., Tian, Y., Li, W., Zhang, J., Feng, M., & Li, Y. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22223 · Cited by 58
miRNAs as biomarkers in prostate cancer
Casanova‐Salas, I., Rubio‐Briones, J., Fernández‐Serra, A., & López‐Guerrero, J. A. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0877-0 · Cited by 61
Hypoxia-regulated gene network in drug resistance and cancer progression
Lin, S.-C., Liao, W.-L., Lee, J., & Tsai, S. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214532755 · Cited by 61
MicroRNAs in pancreatic cancer metabolism
Singh, P. K., Brand, R. E., & Mehla, K. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.63 · Cited by 62
Myc-Induced MicroRNAs Integrate Myc-Mediated Cell Proliferation and Cell Fate
Kim, J. W., Mori, S., & Nevins, J. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0659 · Cited by 60
Han, T., Zhan, W., Gan, M., Liu, F., Yu, B., Chin, Y. E., & Wang, J.-B. (2018) · Cell Research · doi:10.1038/s41422-018-0021-y · Cited by 56
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC
Lee, J.-S., Kang, J. H., Lee, S.-H., Hong, D., Son, J., Hong, K. M., Song, J., & Kim, S.-Y. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.404 · Cited by 56
Functional screen reveals essential roles of miR‐27a/24 in differentiation of embryonic stem cells
Ma, Y., Yao, N., Liu, G., Dong, L., Liu, Y., Zhang, M., Wang, F., Wang, B., Wei, X., Dong, H., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201489957 · Cited by 60
Metabolic changes during prostate cancer development and progression
Beier, A.-M. K., Puhr, M., Stope, M. B., Thomas, C., & Erb, H. H. H. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04371-w · Cited by 68
Mitochondrial-targeted nanoparticles: Delivery and therapeutic agents in cancer
Ganji, C., Muppala, V., Khan, M., Nagaraju, G. P., & Farran, B. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103469 · Cited by 58
Wang, Z., Tang, S., Cai, L., Wang, Q., Pan, D., Dong, Y., Zhou, H., Li, J., Ji, N., Zeng, X., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02670-2 · Cited by 61
c-MYC–miRNA circuitry: A central regulator of aggressive B-cell malignancies
Tao, J., Zhao, X., & Tao, J. (2014) · Cell Cycle · doi:10.4161/cc.27646 · Cited by 61
Towards the definition of prostate cancer-related microRNAs: where are we now?
Gandellini, P., Folini, M., & Zaffaroni, N. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.07.004 · Cited by 59
Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness
Vasseur, S., Tomasini, R., Tournaire, R., & Iovanna, J. (2010) · Cancers · doi:10.3390/cancers2042138 · Cited by 62
Pin, G., Nie, Q., Lan, J., Ge, J., Qiu, Y., & Mao, Q. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.034 · Cited by 58
13C Isotope-Assisted Methods for Quantifying Glutamine Metabolism in Cancer Cells
Zhang, J., Ahn, W. S., Gameiro, P. A., Keibler, M. A., Zhang, Z., & Stephanopoulos, G. N. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00019-4 · Cited by 69
Regulation of hepatic glutamine metabolism by miR-122
Sengupta, D., Cassel, T., Teng, K., Aljuhani, M., Chowdhary, V., Hu, P., Zhang, X., Fan, T. W. ‐., & Ghoshal, K. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.003 · Cited by 58
De novo nucleotide biosynthetic pathway and cancer
Chen, J., Yang, S., Li, Y., Xu, Z., Zhang, P., Song, Q., Yao, Y., & Pei, H. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.04.018 · Cited by 67
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
Lasorsa, F. M., di Meo, N. A., Rutigliano, M., Ferro, M., Terracciano, D., Tătaru, O. S., Battaglia, M., Ditonno, P., & Lucarelli, G. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020910 · Cited by 62
The role of miRNA in motor neuron disease
Kye, M. J., & Gonçalves, I. D. C. G. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00015 · Cited by 55
Wu, H., Li, Z., Yang, P., Zhang, L., Fan, Y., & Li, Z. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.024 · Cited by 59
The mitochondrial bioenergetic capacity of carcinomas
Formentini, L., Martínez‐Reyes, I., & Cuezva, J. M. (2010) · IUBMB Life · doi:10.1002/iub.352 · Cited by 68
Li, J., Csibi, A., Yang, S., Hoffman, G. R., Li, C., Zhang, E., Yu, J. J., & Blenis, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417015112 · Cited by 55
RetractedMetabolic circuits in neural stem cells
Kim, D., Rhee, I., & Paik, J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1686-0 · Cited by 65
MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis
Tomasetti, M., Amati, M., Santarelli, L., & Neužil, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050754 · Cited by 60
Han, T., Guo, M., Zhang, T., Gan, M., Xie, C., & Wang, J.-B. (2017) · Oncotarget · doi:10.18632/oncotarget.14188 · Cited by 55
miR‐148b inhibits glycolysis in gastric cancer through targeting SLC2A1
Ding, X., Liu, J., Liu, T., Ma, Z., Wen, D., & Zhu, J. (2017) · Cancer Medicine · doi:10.1002/cam4.1008 · Cited by 55
MicroRNAs Regulating Reactive Oxygen Species in Cardiovascular Diseases
Gong, Y.-Y., Luo, J., Wang, L., & Huang, Y. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7328 · Cited by 57
Li, S., Shi, Q.-W., Yuan, L., Qin, L., Wang, Y., Miao, Y., Chen, Z., Ling, C., & Qin, W. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0698-2 · Cited by 56
Sen, N., Cross, A. M., Lorenzi, P. L., Khan, J. I., Gryder, B. E., Kim, S., & Caplen, N. J. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22849 · Cited by 58
The secret messages between mitochondria and nucleus in muscle cell biology
Soledad, R. B., Charles, S., & Das, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.03.019 · Cited by 55
CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression
Cano-Crespo, S., Chillarón, J., Junza, A., Fernández‐Miranda, G., García, J., Polte, C., de la Ballina, L. R., Ignatova, Z., Yanes, Ó., Zorzano, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50547-9 · Cited by 64
MYC and the Art of MicroRNA Maintenance
Psathas, J. N., & Thomas‐Tikhonenko, A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014175 · Cited by 55
Cai, X., Zhu, C., Xu, Y., Jing, Y., Yuan, Y., Wang, L., Wang, S., Zhu, X., Gao, P., Zhang, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep26802 · Cited by 54
Self-citationRetractedTargeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
Peterse, E. F. P., Niessen, B., Addie, R. D., de Jong, Y., Cleven, A. H. G., Kruisselbrink, A. B., van den Akker, B. E. W. M., Molenaar, R. J., Cleton-Jansen, A., & Bovée, J. V. M. G. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0050-9 · Cited by 59
Cai, W.-F., Zhang, C., Wu, Y.-Q., 庄桂, Ye, Z., Zhang, C., & Lin, S. (2018) · Cell Research · doi:10.1038/s41422-018-0057-z · Cited by 57
Metadata
- Authors
- Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., & Dang, C. V.
- Affiliations
- Johns Hopkins University (US)
- Teikyo University (JP)
- Corresponding author
- Gao, Ping
- Dang, Chi V.
- Venue
- Nature
- Published
- 2009-02-15
- Volume
- 458
- Issue
- 7239
- Pages
- 762-765
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2729443
- OpenAlex
- W2074873270
- Cited by
- 2,124
- References
- 30
- Citations by year
- 2026: 50 · 2025: 85 · 2024: 105 · 2023: 138 · 2022: 131 · 2021: 142 · 2020: 158 · 2019: 146 · 2018: 146 · 2017: 134 · 2016: 126 · 2015: 145 · 2014: 161 · 2013: 125 · 2012: 144
- FWCI
- 37.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- National Institutes of Health (n01hv28180-13-0-0)
- National Heart, Lung, and Blood Institute (N01 HV-28180, N01 HV028180, R01HL085434)
- National Cancer Institute (R01 CA57341, R01CA057341, R01CA120185, P50CA058236, R37CA051497, P50-CA58236, R01CA051497)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- c-Myc, miR-23a, miR-23b, glutamine metabolism, glutaminolysis, microRNA regulation, cancer metabolism, Warburg effect, PC-3 cells, reactive oxygen species, glutathione synthesis
- MeSH terms
- Glutaminase, Glutamine, Humans, Mitochondria, Gene Expression Regulation, Enzymologic, Proto-Oncogene Proteins c-myc, 3' Untranslated Regions, MicroRNAs, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.